Ibotta, Inc. (IBTA)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$63.03+4.44%
Close 2026-11-04 · 1-day change
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
Research Workspace
Put IBTA beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Application Software is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Adjusted EBITDA margin improves despite revenue pressure: Direct metric needs a verified mapping.
View ThesisRevenue is growing steadily — about 2% over the past year.
View GrowthManagement screens weak on earnings delivery, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 128% growth a year, above the roughly 8% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 41% in its worst 12-month stretch.
View RiskIbotta's return to year-over-year revenue growth must keep compounding. Revenue grew 17% in the latest quarter. The company beat its earnings estimate by 376.9%. It trades at 4.1 times sales. Peers trade at 3.9 times sales. The market expects more growth than we forecast. Our model puts the next miss probability near 60%. The thesis comparison is not yet verified. Peer multiples imply a price about 128% below where it trades. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-04. IBTA is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 10 analysts currently covering IBTA (as of Nov 2026).
Based on 5 Wall Street analysts offering 12-month price targets for IBTA in the last 4 months.
Continue this research
Compare IBTA with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| IBTA Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Application Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put IBTA next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Return to year-over-year revenue growth
Official guidance confirms return to YoY revenue growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $63.03
The last 12 months of price, then the range of analyst 12-month targets from today’s $63.03.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Revenue stabilization and growth
Growth return aligns with revenue stabilization and growth objective.
Advances: Revenue stabilization and growth
Q2 earnings beat indicates revenue growth potential.
Advances: Revenue stabilization and growth
New partnership enhances revenue growth potential.
Advances: Revenue stabilization and growth
Q3 revenue forecast aligns with growth objectives.
Advances: Revenue stabilization and growth
Revenue growth return supports stabilization and growth objective.
Advances: Revenue stabilization and growth
Earnings call confirms revenue growth, enhancing investment thesis.
